The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies

[1]  R. Turcotte,et al.  Image-seq: spatially resolved single-cell sequencing guided by in situ and in vivo imaging , 2022, Nature Methods.

[2]  E. McNeil,et al.  Publisher Correction: Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes , 2022, Pediatric Rheumatology.

[3]  Corbin E. Meacham,et al.  Adiponectin receptors sustain hematopoietic stem cells throughout adulthood by protecting them from inflammation , 2022, Nature Cell Biology.

[4]  L. Xing,et al.  Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice , 2022, The Journal of clinical investigation.

[5]  J. Krijgsveld,et al.  Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss , 2022, Bone Research.

[6]  Xiaolei Tang,et al.  Calcium released by osteoclastic resorption stimulates autocrine/paracrine activities in local osteogenic cells to promote coupled bone formation. , 2022, American journal of physiology. Cell physiology.

[7]  N. LeBrasseur,et al.  Targeted clearance of p21‐ but not p16‐positive senescent cells prevents radiation‐induced osteoporosis and increased marrow adiposity , 2022, Aging cell.

[8]  P. Libby,et al.  B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis , 2022, Nature Immunology.

[9]  Xi-Ping Huang,et al.  Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia , 2022, Cancer discovery.

[10]  P. Schneider,et al.  Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course , 2021, Cancers.

[11]  David M. Evans,et al.  Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis , 2021, The Journal of experimental medicine.

[12]  S. M. Tariq,et al.  A comprehensive review of the impact of obesity on plasma cell disorders , 2021, Leukemia.

[13]  G. Müller-Newen,et al.  Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization , 2021, Leukemia.

[14]  E. Sikora,et al.  A common signature of cellular senescence; does it exist? , 2021, Ageing Research Reviews.

[15]  E. Forsberg,et al.  Acute and endothelial-specific Robo4 deletion affect hematopoietic stem cell trafficking independent of VCAM1 , 2021, PloS one.

[16]  Rachel E. Brewer,et al.  Aged skeletal stem cells generate an inflammatory degenerative niche , 2021, Nature.

[17]  C. Edwards,et al.  Myeloma and marrow adiposity: Unanswered questions and future directions. , 2021, Best practice & research. Clinical endocrinology & metabolism.

[18]  T. L. Andersen,et al.  Myeloma-bone marrow adipocyte axis in tumour survival and treatment response , 2021, British Journal of Cancer.

[19]  A. Chalk,et al.  The characterization of distinct populations of murine skeletal cells that have different roles in B lymphopoiesis. , 2021, Blood.

[20]  P. Tang,et al.  Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis , 2021, Bone Research.

[21]  F. Camargo,et al.  Quantification of bone marrow interstitial pH and calcium concentration by intravital ratiometric imaging , 2021, Nature communications.

[22]  S. Morrison,et al.  A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis , 2021, Nature.

[23]  J. D. Engel,et al.  In situ mapping identifies distinct vascular niches for myelopoiesis , 2021, Nature.

[24]  Nancie J. MacIver,et al.  The Role of the Adipokine Leptin in Immune Cell Function in Health and Disease , 2021, Frontiers in Immunology.

[25]  J. Edwards,et al.  Adiponectin signalling in bone homeostasis, with age and in disease , 2021, Bone Research.

[26]  D. Hume,et al.  Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice , 2021, Journal of Hematology & Oncology.

[27]  Junke Zheng,et al.  Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models. , 2020, The Journal of clinical investigation.

[28]  T. Witham,et al.  Quantitative 3D imaging of the cranial microvascular environment at single-cell resolution , 2020, Nature Communications.

[29]  Gary D Bader,et al.  Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation. , 2020, Blood cancer discovery.

[30]  G. Pei,et al.  Schwann cells promote prevascularization and osteogenesis of tissue-engineered bone via bone marrow mesenchymal stem cell-derived endothelial cells , 2020, Stem cell research & therapy.

[31]  Caroline Wilson,et al.  Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions , 2020, Journal of bone oncology.

[32]  Anjali P. Kusumbe,et al.  Bone Vasculature and Bone Marrow Vascular Niches in Health and Disease , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Hyunsook Kim,et al.  Bone marrow adipogenic lineage precursors (MALPs) promote osteoclastogenesis in bone remodeling and pathologic bone loss , 2020, bioRxiv.

[34]  E. Chiarella,et al.  Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells , 2020, Heliyon.

[35]  Michael R. Tallack,et al.  Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance , 2020, Nature Communications.

[36]  Mingyao Li,et al.  Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment , 2020, eLife.

[37]  J. Gribben,et al.  Bone marrow niches in haematological malignancies , 2020, Nature Reviews Cancer.

[38]  Seung Hun Lee,et al.  Regulation of bone metabolism by megakaryocytes in a paracrine manner , 2020, Scientific Reports.

[39]  Seung Hun Lee,et al.  Regulation of bone metabolism by megakaryocytes in a paracrine manner , 2020, Scientific Reports.

[40]  C. Burger,et al.  Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System , 2020, Frontiers in Immunology.

[41]  D. Spandidos,et al.  Telomere length and telomerase activity in osteoporosis and osteoarthritis , 2019, Experimental and therapeutic medicine.

[42]  Guoji Guo,et al.  Live-animal imaging of native hematopoietic stem and progenitor cells , 2019, Nature.

[43]  P. Waterhouse,et al.  Metalloproteases: On the Watch in the Hematopoietic Niche. , 2019, Trends in immunology.

[44]  H. Pahl,et al.  Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice , 2019, Leukemia.

[45]  T. Hla,et al.  Sphingosine 1-phosphate: Lipid signaling in pathology and therapy , 2019, Science.

[46]  Anjali P. Kusumbe,et al.  Role of angiocrine signals in bone development, homeostasis and disease , 2019, Open Biology.

[47]  A. Trumpp,et al.  Haematopoietic stem cells in perisinusoidal niches are protected from ageing , 2019, Nature Cell Biology.

[48]  John M. Ashton,et al.  Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support , 2019, Leukemia.

[49]  C. López-Otín,et al.  Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging , 2019, Cell stem cell.

[50]  Bin Huang,et al.  CXCL2 attenuates osteoblast differentiation by inhibiting the ERK1/2 signaling pathway , 2019, Journal of Cell Science.

[51]  Patrick M. Helbling,et al.  Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging and inflammation , 2019, bioRxiv.

[52]  Daohong Zhou.  Faculty Opinions recommendation of A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[53]  Monika S. Kowalczyk,et al.  A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia , 2019, Cell.

[54]  Angel Y. F. Kam,et al.  CCR5 Signaling Promotes Murine and Human Hematopoietic Regeneration following Ionizing Radiation , 2019, Stem cell reports.

[55]  Michael R. Elliott,et al.  Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. , 2019, JCI insight.

[56]  R. Satija,et al.  The bone marrow microenvironment at single-cell resolution , 2019, Nature.

[57]  Jianbo He,et al.  Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells. , 2019, Cell stem cell.

[58]  F. Delhommeau,et al.  Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma , 2019, Cells.

[59]  H. Snoeck,et al.  Harnessing Hematopoietic Stem Cell Low Intracellular Calcium Improves Their Maintenance In Vitro. , 2019, Cell stem cell.

[60]  Martin C. Müller,et al.  The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis , 2019, Haematologica.

[61]  N. Rucci,et al.  Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System , 2019, Front. Endocrinol..

[62]  Austin J. Ramme,et al.  Age-related inflammation triggers skeletal stem/progenitor cell dysfunction , 2019, Proceedings of the National Academy of Sciences.

[63]  A. List,et al.  The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. , 2019, Blood.

[64]  M. Raaijmakers,et al.  The mesenchymal niche in MDS. , 2019, Blood.

[65]  S. Morrison,et al.  Restricted Hematopoietic Progenitors and Erythropoiesis Require SCF from Leptin Receptor+ Niche Cells in the Bone Marrow. , 2019, Cell stem cell.

[66]  D. Casero,et al.  Lymphoid-Biased Hematopoietic Stem Cells Are Maintained with Age and Efficiently Generate Lymphoid Progeny , 2019, Stem cell reports.

[67]  L. Calvi,et al.  Impact of aging on bone, marrow and their interactions. , 2019, Bone.

[68]  Xi C. He,et al.  N-Cadherin-Expressing Bone and Marrow Stromal Progenitor Cells Maintain Reserve Hematopoietic Stem Cells. , 2019, Cell reports.

[69]  A. Verma,et al.  Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level , 2018, Nature Medicine.

[70]  P. Frenette,et al.  Neural Regulation of Bone and Bone Marrow. , 2018, Cold Spring Harbor perspectives in medicine.

[71]  Marc N. Wein,et al.  Regulation of Bone Remodeling by Parathyroid Hormone. , 2018, Cold Spring Harbor perspectives in medicine.

[72]  Walter de Back,et al.  Hematopoietic Stem Cells in Perisinusoidal Niches are Protected From Aging , 2018, Experimental Hematology.

[73]  J. E. Park,et al.  Next‐generation proteasome inhibitors for cancer therapy , 2018, Translational research : the journal of laboratory and clinical medicine.

[74]  Samuel E. Zimmerman,et al.  Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow , 2018, Nature Communications.

[75]  U. Germing,et al.  Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia , 2018, Haematologica.

[76]  Sida Zhao,et al.  Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells , 2018, Cell Death & Disease.

[77]  J. Martinez-Barbera,et al.  Paracrine roles of cellular senescence in promoting tumourigenesis , 2018, British Journal of Cancer.

[78]  P. Frenette,et al.  Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct Niches. , 2018, Developmental cell.

[79]  Christopher A. Miller,et al.  Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant. , 2018, JCI insight.

[80]  E. Schwarz,et al.  Osteoblast–osteoclast interactions , 2018, Connective tissue research.

[81]  S. Seno,et al.  Direct cell–cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo , 2018, Nature Communications.

[82]  Yongwon Choi,et al.  Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity , 2018, Nature Reviews Rheumatology.

[83]  Catriona McLean,et al.  Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML , 2018, Cell stem cell.

[84]  V. Gudnason,et al.  Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study. , 2017, Blood advances.

[85]  J. Hong,et al.  Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function. , 2017, Blood advances.

[86]  A. Banfi,et al.  It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration , 2017, Front. Bioeng. Biotechnol..

[87]  M. Dimopoulos,et al.  Mechanisms of bone destruction in multiple myeloma , 2017, European journal of cancer care.

[88]  L. Calvi,et al.  The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression. , 2017, Experimental hematology.

[89]  D. Hume,et al.  CD169+ macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair. , 2017, Biomaterials.

[90]  Y. Degboé,et al.  DKK1 and sclerostin are early markers of relapse in multiple myeloma. , 2017, Bone.

[91]  C. Chen,et al.  Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion , 2017, Leukemia.

[92]  C. Schütte,et al.  Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  N. LeBrasseur,et al.  Targeting cellular senescence prevents age-related bone loss in mice , 2017, Nature Medicine.

[94]  R. Davis,et al.  AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. , 2017, JCI insight.

[95]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[96]  O. Naveiras,et al.  Bone marrow adipocytes promote the regeneration of stem cells and hematopoiesis by secreting SCF , 2017, Nature Cell Biology.

[97]  A. Scialdone,et al.  Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration , 2017, Cell stem cell.

[98]  M. L. Le Beau,et al.  Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model. , 2017, Blood.

[99]  Satoru Miyano,et al.  Clonal evolution in myelodysplastic syndromes , 2017, Nature Communications.

[100]  N. Raje,et al.  Myeloma bone disease: pathogenesis and treatment. , 2017, Clinical advances in hematology & oncology : H&O.

[101]  Nicola J. Brown,et al.  Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells , 2017, Breast Cancer Research.

[102]  F. Kirchhoff,et al.  Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells , 2017, The EMBO journal.

[103]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[104]  Nicolas F. Fernandez,et al.  Differential cytokine contributions of perivascular haematopoietic stem cell niches , 2017, Nature Cell Biology.

[105]  L. Hofbauer,et al.  Myelodysplastic syndromes and bone loss in mice and men , 2017, Leukemia.

[106]  G. Colditz,et al.  Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study , 2016, Journal of the National Cancer Institute.

[107]  J. Cleveland,et al.  The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. , 2016, Blood.

[108]  S. Miyano,et al.  Dynamics of clonal evolution in myelodysplastic syndromes , 2016, Nature Genetics.

[109]  D. Kazandjian.  Multiple myeloma epidemiology and survival: A unique malignancy. , 2016, Seminars in oncology.

[110]  C. Chuah,et al.  CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. , 2016, Cancer cell.

[111]  R. Greil,et al.  T cells in multiple myeloma display features of exhaustion and senescence at the tumor site , 2016, Journal of Hematology & Oncology.

[112]  T. Trotter,et al.  Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone. , 2016, The American journal of pathology.

[113]  Charles P. Lin,et al.  Proximity-Based Differential Single-Cell Analysis of the Niche to Identify Stem/Progenitor Cell Regulators. , 2016, Cell stem cell.

[114]  Kai Hu,et al.  The roles of vascular endothelial growth factor in bone repair and regeneration. , 2016, Bone.

[115]  S. Gupta,et al.  IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation , 2016, Scientific Reports.

[116]  P. Shi,et al.  Type I insulin-like growth factor receptor signaling in hematological malignancies , 2016, Oncotarget.

[117]  N. Nassif,et al.  Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade , 2016, Leukemia.

[118]  R. Adams,et al.  Blood vessel formation and function in bone , 2016, Development.

[119]  N. Munshi,et al.  APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment. , 2016, Blood.

[120]  S. Morrison,et al.  Leptin Receptor Promotes Adipogenesis and Reduces Osteogenesis by Regulating Mesenchymal Stromal Cells in Adult Bone Marrow. , 2016, Cell stem cell.

[121]  L. Suva,et al.  The effects of proteasome inhibitors on bone remodeling in multiple myeloma. , 2016, Bone.

[122]  J. Siddiqui,et al.  Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. , 2016, Physiology.

[123]  Charles P. Lin,et al.  Distinct bone marrow blood vessels differentially regulate hematopoiesis , 2016, Nature.

[124]  C. Betsholtz,et al.  Age-dependent modulation of vascular niches for haematopoietic stem cells , 2016, Nature.

[125]  E. Pietras,et al.  Chronic interleukin-1 drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal , 2016, Nature Cell Biology.

[126]  Ron-Patrick Cadeddu,et al.  Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia , 2016, Leukemia.

[127]  L. Calvi,et al.  Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. , 2016, Blood.

[128]  R. Orlowski,et al.  Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation , 2015, Oncotarget.

[129]  T. Cheng,et al.  Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment , 2015, Stem Cell Research & Therapy.

[130]  K. Matsuo,et al.  EphB4 Expressing Stromal Cells Exhibit an Enhanced Capacity for Hematopoietic Stem Cell Maintenance , 2015, Stem cells.

[131]  Zhiyu Zhao,et al.  Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal , 2015, Nature.

[132]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[133]  C. Panaroni,et al.  PTH Signaling in Osteoprogenitors Is Essential for B‐Lymphocyte Differentiation and Mobilization , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[134]  S. Karlsson,et al.  TGF-β signaling in the control of hematopoietic stem cells. , 2015, Blood.

[135]  Xiang-hang Luo,et al.  MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. , 2015, The Journal of clinical investigation.

[136]  E. Passegué,et al.  Normal and leukemic stem cell niches: insights and therapeutic opportunities. , 2015, Cell stem cell.

[137]  F. Aversa,et al.  The osteoblastic niche in the context of multiple myeloma , 2015, Annals of the New York Academy of Sciences.

[138]  J. Hoeijmakers,et al.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.

[139]  Xiao Li,et al.  Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes , 2014, European journal of haematology.

[140]  T. Suda,et al.  Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. , 2014, Biochemical and biophysical research communications.

[141]  Hans Erik Johnsen,et al.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. , 2014, The Lancet. Oncology.

[142]  Xi C. He,et al.  Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells , 2014, Nature Medicine.

[143]  S. Armstrong,et al.  Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. , 2014, Cell stem cell.

[144]  L. Duong,et al.  PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.

[145]  D. Lai,et al.  Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms , 2014, Nature.

[146]  A. Trumpp,et al.  Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. , 2014, Cell stem cell.

[147]  A. Sundan,et al.  The role of bone morphogenetic proteins in myeloma cell survival. , 2014, Cytokine & growth factor reviews.

[148]  N. Sims,et al.  Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease. , 2014, BoneKEy reports.

[149]  R. Proia,et al.  Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo. , 2014, The Journal of clinical investigation.

[150]  Y. Kunisaki,et al.  Influences of vascular niches on hematopoietic stem cell fate , 2014, International Journal of Hematology.

[151]  K. Ikeda,et al.  Age-related Marrow Adipogenesis Is Linked to Increased Expression of RANKL* , 2014, The Journal of Biological Chemistry.

[152]  R. Adams,et al.  Endothelial Notch activity promotes angiogenesis and osteogenesis in bone , 2014, Nature.

[153]  R. Adams,et al.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.

[154]  C. Shao,et al.  An Osteopontin‐Integrin Interaction Plays a Critical Role in Directing Adipogenesis and Osteogenesis by Mesenchymal Stem Cells , 2014, Stem cells.

[155]  S. Morrison,et al.  The bone marrow niche for haematopoietic stem cells , 2014, Nature.

[156]  R. Rabadán,et al.  Leukemogenesis Induced by an Activating β-catenin mutation in Osteoblasts , 2014, Nature.

[157]  A. Bergman,et al.  Megakaryocytes regulate hematopoietic stem cell quiescence via Cxcl4 secretion , 2013, Nature Medicine.

[158]  F. Zhou,et al.  Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention. , 2013, Blood reviews.

[159]  A. Bergman,et al.  Arteriolar niches maintain haematopoietic stem cell quiescence , 2013, Nature.

[160]  M. Schweizer,et al.  Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C‐C motif) ligand 5 (Ccl5) , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[161]  I. Bruns,et al.  Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells , 2013, Leukemia.

[162]  C. Panaroni,et al.  Interactions Between B Lymphocytes and the Osteoblast Lineage in Bone Marrow , 2013, Calcified Tissue International.

[163]  T. Olson,et al.  Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. , 2013, Blood.

[164]  D. Sipkins,et al.  LYMPHOID NEOPLASIA Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy , 2013 .

[165]  G. Roodman,et al.  Myeloma bone disease: Pathophysiology and management , 2013, Journal of bone oncology.

[166]  S. Nutt,et al.  M-CSF instructs myeloid lineage fate in single haematopoietic stem cells , 2013, Nature.

[167]  I. Bruns,et al.  Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration , 2013, Nature Medicine.

[168]  L. Lagneaux,et al.  Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells , 2013, PloS one.

[169]  Y. Yu,et al.  Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 , 2013, Leukemia.

[170]  S. Morrison,et al.  Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches , 2013, Nature.

[171]  R. Taichman,et al.  The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches , 2013, Journal of cellular biochemistry.

[172]  D. Scadden,et al.  Differential regulation of myeloid leukemias by the bone marrow microenvironment , 2012, Nature Medicine.

[173]  L. Idolazzi,et al.  Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[174]  J. Lévesque,et al.  Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance , 2012, Nature Medicine.

[175]  A. Zallone,et al.  Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual , 2012, Proceedings of the National Academy of Sciences.

[176]  M. Penichet,et al.  TRAF6 activation in multiple myeloma: a potential therapeutic target. , 2012, Clinical lymphoma, myeloma & leukemia.

[177]  A. Rabie,et al.  The role of vascular endothelial growth factor in ossification , 2012, International Journal of Oral Science.

[178]  W. Hiddemann,et al.  Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. , 2012, Blood.

[179]  Nathan C Boles,et al.  Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. , 2012, Blood.

[180]  E. Sitnicka,et al.  Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow , 2012, The Journal of experimental medicine.

[181]  J. Dipersio,et al.  Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. , 2012, Blood.

[182]  R. Kyle,et al.  Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. , 2011, Blood.

[183]  A. Iwama,et al.  Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche , 2011, Cell.

[184]  B. Barlogie,et al.  NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. , 2011, Experimental hematology.

[185]  John M. Ashton,et al.  Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. , 2011, Blood.

[186]  I. Ghobrial,et al.  Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects , 2011, Clinical Cancer Research.

[187]  S. Takeda,et al.  Sympathetic control of bone mass regulated by osteopontin , 2011, Proceedings of the National Academy of Sciences.

[188]  Charles P. Lin,et al.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche , 2011, Nature.

[189]  S. Deaglio,et al.  Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease. , 2011, Leukemia research.

[190]  M. Bitzer,et al.  Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. , 2011, Cancer research.

[191]  R. Pacifici,et al.  Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand , 2010, Proceedings of the National Academy of Sciences.

[192]  D. Kaplan,et al.  Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. , 2010, Cancer research.

[193]  J. Lévesque,et al.  The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization , 2010, Leukemia.

[194]  Yang Liu,et al.  Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. , 2010, The Journal of clinical investigation.

[195]  U. Mellqvist,et al.  Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. , 2010, Blood.

[196]  C. Yao,et al.  Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells. , 2010, Leukemia research.

[197]  S. Rajkumar,et al.  Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. , 2010, Mayo Clinic proceedings.

[198]  H. Kronenberg,et al.  Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss , 2010, PloS one.

[199]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[200]  Liza J. Raggatt,et al.  Cellular and Molecular Mechanisms of Bone Remodeling* , 2010, The Journal of Biological Chemistry.

[201]  David A. Williams,et al.  The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. , 2010, Blood.

[202]  I. Charo,et al.  CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. , 2010, The Journal of clinical investigation.

[203]  K. Yata,et al.  TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth , 2010, PloS one.

[204]  Charles P. Lin,et al.  Bone progenitor dysfunction induces myelodysplasia and secondary leukemia , 2010, Nature.

[205]  Ian A. White,et al.  Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. , 2010, Cell stem cell.

[206]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[207]  S. Shapiro,et al.  Osteoclasts are important for bone angiogenesis. , 2010, Blood.

[208]  J. Fraumeni,et al.  Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. , 2009, Blood.

[209]  Cheang Ly Be,et al.  Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. , 2009, Blood.

[210]  R. Hayes,et al.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. , 2009, Blood.

[211]  G. Daley,et al.  Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment , 2009, Nature.

[212]  A. McMahon,et al.  Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways , 2008, Proceedings of the National Academy of Sciences.

[213]  Siu-Fun Wong,et al.  Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss , 2008, Clinical Cancer Research.

[214]  M. Boccadoro,et al.  A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma , 2008, Cancer.

[215]  David A. Hume,et al.  Osteal Tissue Macrophages Are Intercalated throughout Human and Mouse Bone Lining Tissues and Regulate Osteoblast Function In Vitro and In Vivo1 , 2008, The Journal of Immunology.

[216]  S. Yaccoby,et al.  Role of decorin in the antimyeloma effects of osteoblasts. , 2008, Blood.

[217]  O. Stephens,et al.  Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. , 2008, Blood.

[218]  Daniel Lucas,et al.  Haematopoietic stem cell release is regulated by circadian oscillations , 2008, Nature.

[219]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[220]  A. Wright,et al.  Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis , 2008, Aging cell.

[221]  A. Cope,et al.  Treg cells suppress osteoclast formation: a new link between the immune system and bone. , 2007, Arthritis and rheumatism.

[222]  W. Franz,et al.  Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells. , 2007, American journal of physiology. Endocrinology and metabolism.

[223]  Satoshi Tanaka,et al.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.

[224]  A. Órfão,et al.  New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. , 2007, Blood.

[225]  Kenneth C. Anderson,et al.  Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets , 2007, Nature Reviews Cancer.

[226]  A. Trumpp,et al.  Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment , 2007, Nature Medicine.

[227]  Younghun Jung,et al.  Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. , 2007, Blood.

[228]  N. Mochizuki,et al.  Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. , 2007, Blood.

[229]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[230]  T. Suda,et al.  Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. , 2006, Cell metabolism.

[231]  Ari Elson,et al.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells , 2006, Nature Medicine.

[232]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[233]  Terry M Therneau,et al.  Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.

[234]  E. Brown,et al.  Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor , 2006, Nature.

[235]  P. Frenette,et al.  Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow , 2006, Cell.

[236]  E. Schwarz,et al.  Osteoclast precursors, RANKL/RANK, and immunology , 2005, Immunological reviews.

[237]  S. Rafii,et al.  The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.

[238]  O. Sezer.  Myeloma bone disease , 2005, Hematology.

[239]  B. Williams,et al.  Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. , 2005, Blood.

[240]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[241]  Y. Ko,et al.  Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size , 2005, The Journal of experimental medicine.

[242]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[243]  M. Suga,et al.  Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation , 2005, Clinical Diagnostic Laboratory Immunology.

[244]  T. Therneau,et al.  Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. , 2004, Mayo Clinic proceedings.

[245]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[246]  B. Harder,et al.  Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. , 2004, Blood.

[247]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[248]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[249]  G. Avvisati,et al.  Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[250]  W. Berdel,et al.  Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. , 2003, Blood.

[251]  E. van Marck,et al.  Zoledronic Acid Treatment of 5T2MM‐Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[252]  K. Anderson,et al.  The extracellular calcium Ca2+o-sensing receptor is expressed in myeloma cells and modulates cell proliferation. , 2002, Biochemical and biophysical research communications.

[253]  L. Devy,et al.  Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid , 2002, Journal of Pharmacology and Experimental Therapeutics.

[254]  O. Sezer,et al.  Angiogenesis in multiple myeloma. , 2002, Leukemia research.

[255]  Sundeep Khosla,et al.  Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.

[256]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[257]  S. Rafii,et al.  Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors , 2002, Gene Therapy.

[258]  P. Richardson,et al.  Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications , 2001, Leukemia.

[259]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[260]  A. Spradling,et al.  Stem cells find their niche , 2001, Nature.

[261]  M. Noda,et al.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. , 2001, The Journal of clinical investigation.

[262]  G. Rodan,et al.  In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. , 2000, Endocrinology.

[263]  B. Klein,et al.  Insulin‐like growth factor induces the survival and proliferation of myeloma cells through an interleukin‐6‐independent transduction pathway , 2000, British journal of haematology.

[264]  M. Elmlinger,et al.  Bone Turnover and Growth During and After Continuing Chemotherapy in Children with Acute Lymphoblastic Leukemia , 2000, Pediatric Research.

[265]  R. Fonseca,et al.  Prognostic value of bone marrow angiogenesis in multiple myeloma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[266]  S. Rafii,et al.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[267]  R. Bataille,et al.  Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. , 1996, Blood.

[268]  S. Kasugai,et al.  Regulation of Osteopontin Expression in Osteoblasts , 1995, Annals of the New York Academy of Sciences.

[269]  K. Anderson,et al.  Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. , 1993, Blood.

[270]  J. Kanis,et al.  Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption , 1992, European journal of haematology.

[271]  M. Freeman,et al.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. , 1991, Science.

[272]  Florent Elefteriou,et al.  Control of Bone Remodeling by the Peripheral Sympathetic Nervous System , 2013, Calcified Tissue International.

[273]  Kai-Yan Liu,et al.  Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis , 2012, International Journal of Hematology.

[274]  Toshio Matsumoto,et al.  TGF-β-related mechanisms of bone destruction in multiple myeloma. , 2011, Bone.

[275]  竹内 恭子.  TGF-β inhibition restores terminal osteoblast differentiation to suppress myeloma growth , 2010 .

[276]  H. Fox,et al.  In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression. , 2008, Cellular immunology.

[277]  L. Frölich,et al.  Impact of aging , 2007, NeuroMolecular Medicine.

[278]  T. Hentunen,et al.  Osteocytes inhibit osteoclastic bone resorption through transforming growth factor‐β: Enhancement by estrogen * , 2002, Journal of cellular biochemistry.

[279]  Pamela J. Hines,et al.  Repair and Regeneration. , 2017, Science.

[280]  E. Pietras,et al.  Chronic interleukin-1 drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal , 2016, Nature Cell Biology.